Pre-earnings brief
Reports
Wed, Oct 28, 2026
Est. EPS
—
Est. revenue
—
Implied move
±12.1%
EPS beat rate
75%
DaVita Inc. is a leading provider of kidney care services, primarily through its dialysis centers. Operating in the Health Care sector, the company plays a crucial role in managing chronic kidney disease, which affects millions of people, making its services essential for patient health and well-being.
Last quarter
In Q2-2026, DaVita reported an EPS of $4.02, slightly beating expectations. However, the stock fell by 2.43% the following day, indicating mixed investor sentiment despite the earnings beat.
EPS beat streak
3Q
EPS beat rate
75%
Avg EPS surprise
+2.47%
Avg 1-day reaction
+0.47%
Overall, investors are cautious ahead of the earnings report, especially given the mixed results in previous quarters. The market is looking for signs of consistent revenue growth and cost management.
Bull case
If DaVita can demonstrate strong revenue growth and maintain or improve its EPS, it could signal a robust operational performance, leading to a positive market reaction.
Bear case
Conversely, if the company fails to meet expectations on revenue or shows signs of rising costs, it could lead to further declines in stock price, especially given the recent volatility.
The print will turn on these.
Q1
What is the expected EPS for Q3-2026, and how does it compare to previous quarters?
The EPS figure will be critical in assessing DaVita's profitability and operational efficiency, especially after a mixed performance in the last quarter.
Q2
How is DaVita managing costs in the current economic environment?
Cost management is essential for maintaining profitability, particularly in a sector facing rising expenses and regulatory pressures.
—
Est. EPS
—
Est. Rev
—
Impl. Move
±9.4%
Why consensus could be wrong
The market may be underestimating DaVita's ability to manage costs effectively in a challenging environment, which could lead to better-than-expected margins.
Supporting evidence
DaVita has a history of beating EPS estimates, with a 75% success rate in the last eight quarters.
The options market is pricing in a larger move than historical averages, suggesting that traders expect significant volatility.
Recent trends in healthcare spending may favor companies like DaVita that provide essential services.
Key risk
If DaVita's EPS comes in above $4.10, it could challenge the current cautious sentiment in the market.
Pre-commit to what would confirm each case.
This quarter's performance will be closely watched as it follows a pattern of mixed results, and the market is eager to see if DaVita can stabilize its earnings.
Bull confirmed if
An EPS of $4.10 or better would confirm strong operational performance and investor confidence.
Bear confirmed if
An EPS below $3.80 would raise concerns about profitability and operational challenges.
What the market is pricing for the move.
Implied Move
±12.13%
Historical Avg
±1.7%
The options market is pricing in a significant move, suggesting that investors expect notable volatility around the earnings report.
Options are pricing ±12.1% while DVA has averaged ±1.7% over the last 8 prints — setup is pricing rich.
ATM IV
0.5%
30d HV
31.8%
Cross-company pattern from 30 similar setups.
Prior-quarter beat + options rich in Health Care
Fade rate: 12 of 30 (40%)
This setup has occurred 30 times across Health Care in the last 2 years. 12 of 30 faded and 18 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 3.4%, with a raw directional average of -0.4% (modestly negative historical bias).
Smart-money positioning from the most recent 13F filings.
Institutional
48.38%
of float
Insider
46.91%
of float
Holders
860
institutions
Top Holders· as of Jun 2026
Berkshire Hathaway, Inc
28,880,209 sh · $5.1B
45.27%
-4.0%
Likely market behavior by outcome. Not investment advice.
Beat & raise
History suggests that a strong earnings beat could lead to a positive stock reaction, with an average 1-day move of +0.88%.
In line / cautious
If results are in line with expectations but management's commentary is cautious, the stock may see muted movement as investors weigh future growth.
Miss
A miss could lead to a decline, with historical data indicating an average 1-day drop of -0.78% when expectations are not met.
The lines on the call that would change the story.
Blackrock Inc.
2,460,987 sh · $435.1M
3.86%
-11.1%
Vanguard Capital Management LLC
2,101,425 sh · $371.5M
3.29%
-3.6%
Morgan Stanley
1,601,710 sh · $283.2M
2.51%
-3.9%
Vanguard Portfolio Management LLC
1,377,914 sh · $243.6M
2.16%
-6.9%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.